The TGF-β pathway promotes cell cycle arrest and apoptosis in early stage tumors but promotes tumor progression and metastasis in advanced disease, either by inactivating core components of the pathway, such as TGF-β receptors, or by inducing downstream alterations that disable only the tumor-suppressive arm of the pathway [6–8]. The gene discussed is TGFB1; the disease is neoplasm.